Andries E Budding (Andries Budding)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Body Mass Index

Silver Nanoparticles

Acute Kidney Injury

Top Venues

JMIR research protocols

inBiome

VU University Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

inBiome Feb 07 2019

Netherlands

CEO

Education History

VU University Medical Center

Netherlands

PHD :: Medical Microbiology

University of Groningen

Netherlands

PHD

Leiden University

Netherlands

BSC

Publications

Thomas H Dierikx, Andries E Budding, Martine Bos, Henriëtte van Laerhoven, Sophie van der Schoor, Hendrik J Niemarkt, Marc Benninga, Anton van Kaam, Douwe Visser, Tim de Meij
Potential of Molecular Culture in Early Onset Neonatal Sepsis Diagnosis: A Proof of Principle Study. Microorganisms 11 (4) (2023)
Thomas H Dierikx, Andries E Budding, Martine Bos, Henriëtte van Laerhoven, Sophie van der Schoor, Hendrik J Niemarkt, Marc Benninga, Anton van Kaam, Douwe Visser, Tim de Meij
Potential of Molecular Culture in Early Onset Neonatal Sepsis Diagnosis: A Proof of Principle Study. Microorganisms 11 (4) (2023)
Thomas H Dierikx, Andries E Budding, Martine Bos, Henriëtte van Laerhoven, Sophie van der Schoor, Hendrik J Niemarkt, Marc Benninga, Anton van Kaam, Douwe Visser, Tim de Meij
Potential of Molecular Culture in Early Onset Neonatal Sepsis Diagnosis: A Proof of Principle Study. Microorganisms 11 (4) (2023)
Thomas H Dierikx, Andries E Budding, Martine Bos, Henriëtte van Laerhoven, Sophie van der Schoor, Hendrik J Niemarkt, Marc Benninga, Anton van Kaam, Douwe Visser, Tim de Meij
Potential of Molecular Culture in Early Onset Neonatal Sepsis Diagnosis: A Proof of Principle Study. Microorganisms 11 (4) (2023)
Jeske van Pamelen, Lynn van Olst, Andries E Budding, null null, Elizabeth C M de Lange, Leo H Visser
Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study. JMIR research protocols 9 (7) (2020)